Sm. Vlajkovic et al., THE PHARMACOLOGY AND KINETICS OF ECTO-NUCLEOTIDASES IN THE PERILYMPHATIC COMPARTMENT OF THE GUINEA-PIG COCHLEA, Hearing research, 117(1-2), 1998, pp. 71-80
This study investigated the characteristics of ecto-nucleotidases in t
issues lining the perilymphatic cavity of the cochlea. The perilymphat
ic space of the isolated guinea-pig cochlea was maintained with oxygen
ated artificial perilymph (AP) perfused at a rate of 100 mu l/min. Fol
lowing AP perfusion, either adenosine triphosphate (ATP), adenosine di
phosphate (ADP) or adenosine monophosphate (AMP) was introduced into s
cala tympani, and perfusion arrested for 2 min for substrate incubatio
n with cochlear tissues. Effluent collected from the cochlea was assay
ed for adenine nucleotide metabolites by reverse-phase high-performanc
e liquid chromatography (RP-HPLC). Extracellular ATP and ADP were rapi
dly and sequentially hydrolysed to adenosine by Ca2+/Mg2+-dependent an
d Ca2+/Mg2+-independent enzymatic mechanisms. The degradation of extra
cellular ATP, ADP and AMP occurred in the presence of intact tissues,
as demonstrated by the limited lactate dehydrogenase (LDH) activity (0
-2.2%). ATPase activity was not affected by inhibitors of intracellula
r ATPases (oligomycin, ouabain, N-ethylmaleimide, 100 mu M NaN3) and n
on-specific alkaline phosphatase (beta-glycerophosphate). The hydrolys
is of ATP was inhibited by 5 mM NaN3, suramin, ATP gamma S, La3+ and C
TP, the hydrolysis of ADP by beta,gamma-imidoATP, and AMP degradation
by alpha,beta-methyleneADP. Ecto-ATPase, ecto-ADPase and ecto-5'-nucle
otidase followed Michaelis-Menten hyperbolic kinetics, with estimated
K-m values of 2282 mu M, 6619 mu M and 881 mu M, respectively. Our res
ults indicate the presence of considerable ecto-nucleotidase activity
within scala tympani of the cochlea, and support its role as the termi
nating mechanism for P2 receptor signalling known to occur in the coch
lea. A competition plot is consistent with ATP and ADP degradation med
iated by the same enzyme (ecto-ADP diphosphohydrolase) with two differ
ent catalytic sites. (C) 1998 Elsevier Science B.V.